Sanofi Will Maintain “Massive” Investment Behind Ambien CR
This article was originally published in The Pink Sheet Daily
Company will continue to invest in sales reps, DTC ads for sleep aid in line with competitors' spending.
You may also be interested in...
FDA approves the first generic versions of Sanofi-Aventis’ immediate-release zolpidem.
Sleep aid introduction is being promoted with 3,500 sales reps, DTC ads breaking mid-November.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.